Kala Bio (KALA) Shares Issued (2016 - 2025)
Kala Bio (KALA) posted Shares Issued of $1.2 million for Q4 2025, up 28523.98% sequentially from $4154.0 in Q3 2025, and up 35.43% YoY from $878003.0 in Q4 2024.
Kala Bio (KALA) Shares Issued (2016 - 2025) Analysis & Trends
Kala Bio has reported Shares Issued for 10 years, with the latest figure at $1.2 million in Q4 2025.
- Quarterly Shares Issued rose 35.43% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (up 35.43% YoY) and the FY2025 annual result came in at $1.2 million, up 35.43% from the prior year.
- Shares Issued climbed to $1.2 million in Q4 2025 per KALA's latest filing, from $4154.0 in the prior quarter.
- Over five years, Shares Issued peaked at $1.2 million in Q4 2025 and troughed at $4154.0 in Q3 2025.
- A 5-year average of $332482.8 and a median of $205687.0 in 2024 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2023 and 2025: Shares Issued surged 224.93% in 2023, then tumbled 98.24% in 2025.
- Over 5 years, Shares Issued stood at $199805.0 in 2021, then grew by 3.21% to $206221.0 in 2022, then soared by 224.93% to $670064.0 in 2023, then jumped by 31.03% to $878003.0 in 2024, then jumped by 35.43% to $1.2 million in 2025.
- According to Business Quant data, Shares Issued over the past three periods registered $1.2 million, $4154.0, and $184154.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Kala Bio | 9.87 Mn | 9.87 Mn | - | 417.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.19 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 4,154.00 |
| Sep 30, 2025 | 4,154.00 |
| Jun 30, 2025 | 184,154.00 |
| Jun 30, 2025 | 184,154.00 |
| Mar 31, 2025 | 231,816.00 |
| Mar 31, 2025 | 231,816.00 |
| Dec 31, 2024 | 878,003.00 |
| Dec 31, 2024 | 878,003.00 |
| Sep 30, 2024 | 236,576.00 |
| Sep 30, 2024 | 236,576.00 |
| Jun 30, 2024 | 205,687.00 |
| Jun 30, 2024 | 205,687.00 |
| Mar 31, 2024 | 92,062.00 |
| Mar 31, 2024 | 92,062.00 |
| Dec 31, 2023 | 670,064.00 |
| Dec 31, 2023 | 670,064.00 |
| Sep 30, 2023 | 112,597.00 |
| Sep 30, 2023 | 112,597.00 |